Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...